IFNAR1 and myelodysplastic syndrome: Therefore, the beneficial effect of Ifnar1 deletion in Abin1Q478H/Q478H mice serves as a promising novel strategy for treating hematopoietic deficiencies and may offer new opportunities for therapeutic interventions in patients suffering from hematopoietic diseases, including del(5q) MDS.